Hydrogen Peroxide
Regulatory activity · MHRAAlso known as ActiveOxy, Astri-UC, Eskata, Oxy Gard+16 more
ActiveOxy, Astri-UC, Eskata, Oxy Gard, Oxycide, Perimax Perio Rinse, Periogel, Perox-A-Mint, Peroxi-Fresh, Peroxide D'hydrogene, Peroxy Shield, Peroxyde D'hydrogene, Peroxyl, Preop, Proxacol, Pur-Oxy, Superoxol, Teat Dip-HP10, Hydrogen dioxide, Hydroperoxide.
Recent clinical, regulatory, research and industry developments relating to this drug.
Antiseptic Effects on the Dental Implant Internal Surface Microbiome
Evaluation of Aerosol in a Dental Clinic
Exploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management.
Drug Safety Update: Hydrogen peroxide: reminder of risk of gas embolism when used in surgery
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Contains public sector information from the Medicines and Healthcare products Regulatory Agency (MHRA) licensed under the Open Government Licence (OGL v3).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Evaluation of Aerosol in a Dental Clinic
Recent completions
Trials that read out recently, adding to the completed evidence base.
Evaluation of Aerosol in a Dental Clinic
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Archives of toxicology1
- Biomolecules1
- Brain : a journal of neurology1
- Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology1
- eLife1
- Frontiers in immunology1
- Ali Q1
- Alomar SY1
- Alrumaihi F1
- Alwasel SH1
- Anwar S1
- Ashfaq M1
- Babiker AY1
- Bista P1
- Bioelectronics Materials and Devices Laboratory1
- Biomedical Research Center1
- Center for Computational and Integrative Biology and Department of Computer Science1
- Center for Free Radical Biology1
- College of Applied Medical Sciences1
- College of Science1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 4 of the same disease areas as Hydrogen Peroxide in the shared literature.
Studied across 3 of the same disease areas as Hydrogen Peroxide in the shared literature.
Studied across 3 of the same disease areas as Hydrogen Peroxide in the shared literature.
Studied across 2 of the same disease areas as Hydrogen Peroxide in the shared literature.
Studied across the same disease area as Hydrogen Peroxide in the shared literature.
Studied across the same disease area as Hydrogen Peroxide in the shared literature.
Frequently co-studied with Hydrogen Peroxide in the research literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.